FUNI.US Hypha Labs, Inc.

Healthcare Diagnostics & Research USA Stocks
0.0029 USD
Close of Nov 14, 2026
0.0020 0.0400
Market cap
USD 475K
P/E
-
P/B
11.43x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is FUNI.US undervalued?

Graham number

The Graham number of Hypha Labs, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hypha Labs, Inc. fundamental analysis

No fundamental analysis for Hypha Labs, Inc. yet.

Hypha Labs, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hypha Labs, Inc.

Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Full company profile